Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 2802-2806

  Sadzot Delvaux, Catherine ^a,c   Kinchington, Paul R ^b   Debrus, Serge ^c   Rentier, Bernard ^c   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 63, HUMAN HERPESVIRUS 3; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HERPES ZOSTER; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; VARICELLA ZOSTER VIRUS; VIRUS LATENCY;

ADULT; ANTIGENS, VIRAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS; VIRUS LATENCY;

EID: 0031571798     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weller, T. H., and H. M. Witton. 1958. The etiologic agents of varicella and herpes zoster: isolation, propagation and culture characteristics in vitro. J. Exp. Med. 108:843.
2. Croen, K. D., J. M. Ostrove, L. J. Dragovic, and S. E. Straus. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. USA 85:9773.
3. Cohrs, R. J., M. Barbour, and D. H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Viral. 70:2789.
4. Debrus, S., C. Sadzot-Delvaux, A. J. Nikkels, J. Piette, and B. Rentier. 1995. Varicella-zoster virus gene 63 encodes an immediate early protein abundantly expressed during latency. J. Virol. 69:3240.
5. Mahalingam, R., M. Wellish, R. Cohrs, S. Debrus, J. Piette, B. Rentier, and D. H. Gilden. 1996. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. USA 93:2122.
6. Kinchington, P. R., D. Bookey, and S. E. Turse. 1995. The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF61, are associated with purified virus particles. J. Virol. 69:4274.
7. Nikkels, A. F., S. Debrus, C. Sadzot-Delvaux, J. Piette, B. Rentier, and G. E. Piérard. 1995. Immunochemical identification of varicella-zoster virus gene 63encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use. J. Med. Virol. 47:342.
8. Hayward, A. R., and M. Herderger. 1987. Lymphocyte responses to varicella-zoster virus in the elderly. J. Clin. Immunol. 7:174.
9. Berger, R., G. Florent, and M. Just. 1981. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect. Immun. 32:24.
10. Arvin, A. M., R. B. Pollard, L. E. Ramussen, and T. C. Merigan. 1980. Cellular and humoral immunity in lymphoma patients. J. Clin. Invest. 65:869.
11. Sorensen, O. S., S. Haahrs, A. Moller-Larson, and K. Wildenhoff. 1980. Cell mediated and humoral immunity to herpes viruses during and after herpes zoster infections. Infect. Immun. 29:369.
12. Arvin, A. M., E. Kinney-Thomas, K. Shriver, C. Grose, C. M. Koropchak, E. Scranton, A. E. Wittek, and P. S. Diaz. 1986. Immunity to varicella-zoster viral glycoproteins, gpI (90/58) and gpIII (gpI18), and to a non glycosylated protein, p170. J. Immunol. 137:1346.
13. Arvin, A. M. 1994. The T-lymphocyte response to varicella-zoster virus and its relevance to vaccine development. Rev. Med. Virol. 4:161.
14. Kinchington, P. R., J. K. Houghland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992. Varicella-zoster virus IE62 protein is a major virion component. J. Virol. 66:359.
15. Diaz, P. S., S. Smith, E. Hunter, and A. M. Arvin. 1989. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J. Immunol. 142:636.
16. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods 49:1211.
17. Arvin, A. M., J. F. Moffat, and R. Redman. 1996. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv. Virus Res. 46:263.
18. Giller, R. H., S. Winistorfer, and C. Grose. 1989. Cellular and humoral immunity to varicella-zoster virus glycoproteins in immune and susceptible human subjects. J. Infect. Dis. 160:919.
19. Sharp, M., K. Terada, A. Wilson, S. Nader, P. E. Kinchington, W. T. Ruyechan, J. Hay, and A. M. Arvin. 1992. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852.
20. Zhang, Y., M. Cosyns, M. J. Levin, and A. R. Hayward. 1994. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98:128.
21. + phenotype. J. Immunol. 146:257.